NCT01476332 - Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Dry Eye

Interventions

DRUG

cis-urocanic acid 0,5% eye drops

one drop three times a day, applied on one eye at Part 1 and on both eyes at Part 2

DRUG

cis-urocanic acid 2.5% eye drops

one drop three times a day, applied on one eye at Part 1 and on both eyes at Part 2

DRUG

Placebo for cis-UCA, eye drops

one drop three times a day, applied on one eye at Part 1 and on both eyes at Part 2

Trial Locations (1)

Kuopio University Hospital, Department of Ophthalmology, Kuopio